AstraZeneca hits sales of nearly £200m from Covid-19 jabs

AstraZeneca has revealed it banked revenues of 275 million US dollars (£197 million) in the first three months of the year from sales of its Covid-19 vaccine, delivering 68 million doses worldwide.